查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1523029

基於水凝膠的藥物傳輸系統市場報告：2030 年趨勢、預測與競爭分析

Hydrogel-Based Drug Delivery System Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

基於水凝膠的藥物傳遞系統的趨勢和預測

到 2030 年，全球水凝膠給藥系統市場預計將達到 112 億美元，2024 年至 2030 年複合年成長率為 6.8%。此市場的主要促進因素是藥物輸送系統研發投資的增加以及藥物輸送系統控制釋放需求的增加。全球水凝膠給藥系統市場的未來性充滿希望，皮下、眼科和口服市場存在機會。

基於水凝膠的藥物傳輸系統（按細分市場）

本報告按聚合物原料、遞送途徑和地區對全球水凝膠藥物遞送系統進行了預測。

基於水凝膠的藥物傳輸系統市場洞察

Lucintel 預測，在預測期內，天然原料仍將是最大的細分市場，因為水凝膠在細胞黏附特性方面表現出有利的特性。

在這個市場中，眼科產品將繼續成為最大的細分市場。

由於可以獲得包含現代治療費用的有效報銷，北美在預測期內將繼續成為最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，基於水凝膠的藥物輸送系統的全球市場預計將達到 112 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，以水凝膠為基礎的藥物傳遞系統的全球市場預計將以6.8%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3.此市場的主要促進因素是藥物輸送系統研發投資的增加以及藥物輸送系統控制釋放需求的增加。

Q4.市場的主要細分市場是：

A4. 以水凝膠為基礎的藥物傳遞系統市場未來性廣闊，在皮下、眼科和口腔市場都有機會。

Q5.市場的主要企業是：

A5. 水凝膠給藥系統的主要企業如下：

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，天然原料在預測期內將繼續成為最大的細分市場，因為它們在細胞黏附特性方面表現出有利的特性。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於可以提供包含現代治療費用的有效報銷，預計北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球水凝膠給藥系統市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球水凝膠給藥系統市場趨勢（2018-2023）與預測（2024-2030）
  • 聚合物原料水凝膠給藥系統的全球市場
    • 自然的
    • 合成
    • 混合
  • 按遞送途徑分類的水凝膠藥物遞送系統的全球市場
    • 皮下的
    • 眼科
    • 口腔
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的水凝膠給藥系統市場
  • 北美水凝膠給藥系統市場
  • 歐洲水凝膠給藥系統市場
  • 亞太水凝膠給藥系統市場
  • 其他區域性水凝膠給藥系統市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 聚合物原料的全球水凝膠給藥系統市場成長機會
    • 基於水凝膠的藥物遞送系統按遞送途徑的市場成長機會
    • 全球水凝膠給藥系統市場成長機會（按地區）
  • 全球水凝膠給藥系統市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球水凝膠給藥系統市場的產能
    • 全球水凝膠給藥系統市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals
簡介目錄

Hydrogel-Based Drug Delivery System Trends and Forecast

The future of the global hydrogel-based drug delivery system market looks promising with opportunities in the subcutaneous, ocular, and oral cavity markets. The global hydrogel-based drug delivery system market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increasing investment in research and development for drug delivery systems and growing demand for controlled release of drug delivery systems.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hydrogel-Based Drug Delivery System by Segment

The study includes a forecast for the global hydrogel-based drug delivery system by polymer origin, route, and region.

Hydrogel-Based Drug Delivery System Market by Polymer Origin [Shipment Analysis by Value from 2018 to 2030]:

  • Natural
  • Synthetic
  • Hybrid

Hydrogel-Based Drug Delivery System Market by Route [Shipment Analysis by Value from 2018 to 2030]:

  • Subcutaneous
  • Ocular
  • Oral Cavity
  • Others

Hydrogel-Based Drug Delivery System Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Hydrogel-Based Drug Delivery System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hydrogel-based drug delivery system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hydrogel-based drug delivery system companies profiled in this report include-

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals

Hydrogel-Based Drug Delivery System Market Insights

Lucintel forecasts that natural will remain the largest segment over the forecast period as they exhibit favorable traits for cell adhesion properties.

Within this market, ocular will remain the largest segment.

North America will remain the largest region over the forecast period due to availability of effective reimbursement that encompasses the costs of contemporary treatments.

Features of the Global Hydrogel-Based Drug Delivery System Market

Market Size Estimates: Hydrogel-based drug delivery system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hydrogel-based drug delivery system market size by polymer origin, route, and region in terms of value ($B).

Regional Analysis: Hydrogel-based drug delivery system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different polymer origin, routes, and regions for the hydrogel-based drug delivery system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hydrogel-based drug delivery system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hydrogel-based drug delivery system market size?

Answer: The global hydrogel-based drug delivery system market is expected to reach an estimated $11.2 billion by 2030.

Q2. What is the growth forecast for hydrogel-based drug delivery system market?

Answer: The global hydrogel-based drug delivery system market is expected to grow with a CAGR of 6.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the hydrogel-based drug delivery system market?

Answer: The major drivers for this market are increasing investment in research and development for drug delivery systems and growing demand for controlled release of drug delivery systems.

Q4. What are the major segments for hydrogel-based drug delivery system market?

Answer: The future of the hydrogel-based drug delivery system market looks promising with opportunities in the subcutaneous, ocular, and oral cavity markets.

Q5. Who are the key hydrogel-based drug delivery system market companies?

Answer: Some of the key hydrogel-based drug delivery system companies are as follows:

  • Galderma
  • Blairex Laboratories
  • Johnson & Johnson
  • Bausch and Lomb
  • Medtronic
  • Ocular Therapeutix
  • Ferring
  • Endo International
  • Akorn
  • Tolmar Pharmaceuticals

Q6. Which hydrogel-based drug delivery system market segment will be the largest in future?

Answer: Lucintel forecasts that natural will remain the largest segment over the forecast period as they exhibit favorable traits for cell adhesion properties.

Q7. In hydrogel-based drug delivery system market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of effective reimbursement that encompasses the costs of contemporary treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hydrogel-based drug delivery system market by polymer origin (natural, synthetic, and hybrid), route (subcutaneous, ocular, oral cavity, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hydrogel-Based Drug Delivery System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hydrogel-Based Drug Delivery System Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hydrogel-Based Drug Delivery System Market by Polymer Origin
    • 3.3.1: Natural
    • 3.3.2: Synthetic
    • 3.3.3: Hybrid
  • 3.4: Global Hydrogel-Based Drug Delivery System Market by Route
    • 3.4.1: Subcutaneous
    • 3.4.2: Ocular
    • 3.4.3: Oral Cavity
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hydrogel-Based Drug Delivery System Market by Region
  • 4.2: North American Hydrogel-Based Drug Delivery System Market
    • 4.2.1: North American Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.2.2: North American Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
  • 4.3: European Hydrogel-Based Drug Delivery System Market
    • 4.3.1: European Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.3.2: European Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
  • 4.4: APAC Hydrogel-Based Drug Delivery System Market
    • 4.4.1: APAC Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.4.2: APAC Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others
  • 4.5: ROW Hydrogel-Based Drug Delivery System Market
    • 4.5.1: ROW Hydrogel-Based Drug Delivery System Market by Polymer Origin: Natural, Synthetic, and Hybrid
    • 4.5.2: ROW Hydrogel-Based Drug Delivery System Market by Route: Subcutaneous, Ocular, Oral Cavity, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Polymer Origin
    • 6.1.2: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Route
    • 6.1.3: Growth Opportunities for the Global Hydrogel-Based Drug Delivery System Market by Region
  • 6.2: Emerging Trends in the Global Hydrogel-Based Drug Delivery System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hydrogel-Based Drug Delivery System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hydrogel-Based Drug Delivery System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Galderma
  • 7.2: Blairex Laboratories
  • 7.3: Johnson & Johnson
  • 7.4: Bausch and Lomb
  • 7.5: Medtronic
  • 7.6: Ocular Therapeutix
  • 7.7: Ferring
  • 7.8: Endo International
  • 7.9: Akorn
  • 7.10: Tolmar Pharmaceuticals